Standout Papers

Inhibition of the Hedgehog Pathway in Advanced Basal-Cell C... 1999 2026 2008 2017 822
  1. Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma (2009)
    Daniel D. Von Hoff, Patricia LoRusso et al. New England Journal of Medicine
  2. Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449 (2009)
    Charles M. Rudin, Christine L. Hann et al. New England Journal of Medicine
  3. Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non–Small-Cell Lung Cancer (2015)
    Joseph McLaughlin, Gang Han et al. JAMA Oncology
  4. Multicenter Phase II Study of Capecitabine in Paclitaxel-Refractory Metastatic Breast Cancer (1999)
    Joanne L. Blum, Stephen E. Jones et al. Journal of Clinical Oncology
  5. Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial (2014)
    Ian E. Krop, Sung‐Bae Kim et al. The Lancet Oncology
  6. Inhibition of the PI3K/AKT/mTOR Pathway in Solid Tumors (2016)
    Patricia LoRusso Journal of Clinical Oncology
  7. Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trial (2017)
    Ian E. Krop, Sung‐Bae Kim et al. The Lancet Oncology
  8. The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development (2024)
    Raffaele Colombo, Paolo Tarantino et al. Cancer Discovery

Immediate Impact

18 by Nobel laureates 9 from Science/Nature 121 standout
Sub-graph 1 of 19

Citing Papers

Cell death
2024 Standout
Polymeric Nanoparticles for Drug Delivery
2024 Standout

Works of Patricia LoRusso being referenced

Mirzotamab clezutoclax as monotherapy and in combination with taxane therapy in relapsed/refractory solid tumors: Dose expansion results.
2023
Phase I Study of PSMA-Targeted Docetaxel-Containing Nanoparticle BIND-014 in Patients with Advanced Solid Tumors
2016

Author Peers

Author Last Decade Papers Cites
Patricia LoRusso 10965 10660 4274 560 21.3k
William D. Figg 9855 11342 4342 599 24.6k
Anthony W. Tolcher 7038 8671 3630 431 16.1k
Christoph Zielinski 9866 4938 5567 497 20.3k
Charles Dumontet 8148 8674 2115 370 19.8k
Masakazu Toi 10580 7817 5860 651 20.9k
John Crown 12728 7262 4664 413 19.6k
Alex A. Adjei 11339 12744 8009 467 25.6k
Giampaolo Tortora 13500 9748 7644 619 23.7k
Naoto T. Ueno 10744 5453 3626 537 19.9k
Nicola Normanno 10221 8217 5459 354 18.0k

All Works

Loading papers...

Rankless by CCL
2026